Thyrocare Technologies Ltd.
Snapshot View

648.10 +7.80 ▲1.2%

07 December 2022, 04:01:48 PM
Volume: 28,585

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.thyrocare.com
Market Cap 3,418.49 Cr.
Enterprise Value(EV) 3,406.60 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 15.10 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 42.40 Trailing Twelve Months Ending 2022-09
Industry PE 50.11 Trailing Twelve Months Ending 2022-09
Book Value / Share 93.07 Trailing Twelve Months Ending 2022-09
Price to Book Value 6.88 Calculated using Price: 640.00
Dividend Yield 2.32 Period Ending 2022-03
No. of Shares Subscribed 5.29 Cr. 52,930,043 Shares
FaceValue 10
Company Profile
Thyrocare Technologies is an India-based healthcare service provider. The Company operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia. The Company offers technologies, including Chemiluminescence Immunoassay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Ion Selective Electrode (ISE), Fluorescence Flow Cytometry, Nephelometry, Photometry, Liquid Chromatography Mass Spectrometry (LC-MS), Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) and Cytogenetics. The Company offers cancer diagnosis and water testing through its brands Nueclear and Whaters, respectively.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.22%
1 Week
+2.74%
1 Month
-2.69%
3 Month
-1.53%
6 Month
-3.51%
1 Year
-40.29%
2 Year
-38.01%
5 Year
-3.49%
10 Year
8 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 15.98 16.22 11.20 22.16 19.41 22.13 28.76 37.22
Return on Capital Employed (%) 24.57 25.66 21.05 33.93 31.36 35.14 38.52 48.28
Return on Assets (%) 13.41 14.09 10.20 20.59 17.93 18.73 22.44 30.90

Balance Sheet View Details >>

Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 276 366 408 443 435 367 427 527 493
Non Curr. Liab. 9 10 9 10 14 21 18 10 5
Curr. Liab. 7 31 18 20 21 82 95 65 66
Minority Int. 36
Equity & Liab. 328 407 434 474 470 469 540 601 563
Non Curr. Assets 218 273 285 332 334 317 300 331 327
Curr. Assets 111 134 150 142 136 152 240 270 236
Misc. Exp. not W/O
Total Assets 328 407 434 474 470 469 540 601 563

Profit Loss View Details >>

Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 183 241 304 356 403 434 495 589 511
Other Income 8 7 12 23 10 7 12 29 6
Total Income 191 248 317 380 413 441 507 618 517
Total Expenditure -110 -147 -189 -212 -249 -261 -323 -354 -369
PBIDT 81 101 128 168 164 180 184 264 148
Interest 0 -1 0 0 -1 -2 -1 -2 -2
Depreciation -13 -18 -18 -20 -26 -32 -30 -34 -36
Taxation -24 -30 -39 -52 -53 -52 -39 -52 -30
Exceptional Items -27 -2 -7
PAT 44 52 43 93 85 88 113 176 79
Minority Interest 1
Share Associate 1 1 0 0 1
Other Related Items -1 0
Consolidated Net Profit 45 52 43 93 85 89 112 176 80
Adjusted EPS 9 10 8 17 16 17 21 33 15

Cash Flow View Details >>

Particulars 8 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 34 68 90 107 100 168 115 113
Cash Fr. Inv. -18 -18 -42 -43 -12 1 -49 -24
Cash Fr. Finan. -23 -45 -49 -64 -94 -165 -62 -89
Net Change -6 5 0 0 -5 4 4 0
Cash & Cash Eqvt 5 10 10 10 5 9 13 14

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 66.11 66.14 66.14 66.14 71.22 71.18 71.18 71.18 71.14
Public 33.89 33.86 33.86 33.86 28.78 28.82 28.82 28.82 28.86
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 100.00 100.00 100.00 100.00 100.00

Announcements View Details >>

Tue, 29 Nov 2022
Schedule of Analysts/Institutional Investor Meet/Con. Call
Thyrocare Technologies Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call
Fri, 25 Nov 2022
Related Party Transaction
Thyrocare Technologies Limited has informed the Exchange about related party transaction for the period ended September 2022.
Fri, 25 Nov 2022
Schedule of Analysts/Institutional Investor Meet/Con. Call
Thyrocare Technologies Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call

Technical Scans View Details >>

Wed, 07 Dec 2022
Close Crossing Last Week High Close Crossing Last Week High
Closing Above Previous High Closing Above Previous High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 1 Year High Decrease 1 Year
Closing Near 50 SMA Closing Near 50 SMA

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 244,600.20 1,017.75 -1.5%
Cipla Ltd. 89,185.65 1,105.30 -0.4%
Divi's Laboratories Ltd. 88,620.05 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. 72,619.02 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. 67,995.76 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. 55,031.23 1,629.00 +0.9%
Abbott India Ltd. 42,993.71 20,208.95 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 59.59 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-09 34.76 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 29.63 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.32 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 80.98 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.05 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-09 48.76 20,208.95 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.60 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-09 4.08 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 7.31 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.49 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.36 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.03 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-09 15.84 20,208.95 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 0.00 20,208.95 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 29.95 20,208.95 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 29.95 20,208.95 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,208.95 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,017.75 -1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,105.30 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,338.25 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,361.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,727.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,629.00 +0.9%
Abbott India Ltd. Standalone 2022-03 798.70 20,208.95 +0.1%

FAQ's On Thyrocare Technologies Ltd.

What is Thyrocare Tech. share price?

Can I buy Thyrocare Tech. shares now?

What is the Dividend Yield of Thyrocare Tech.?

What is the Market Cap of Thyrocare Tech.?

What are the key metrics to analyse Thyrocare Tech.?

What is the 52 Week High and Low of Thyrocare Tech.?

What is the trend of Thyrocare Tech. share price?